Search research articles
Contact Us
Filters
Showing results (11-20 of 1,016) with videos related to
Page
of 102
Sort By:
Cancer
|
April 3, 2020
In our patient-centered era, it is time we gave patient-reported outcomes their due
David Cella
The Patient
|
July 2, 2022
Concerns about the Responsiveness of Generic Measures and the Search for a "Minimally" Important Change: Today's PRO Red Herrings
David Cella
Seminars in Oncology
|
March 20, 2003
Impact of ZD1839 on non-small cell lung cancer-related symptoms as measured by the functional assessment of cancer therapy-lung scale
David Cella
Cancer Treatment Reviews
|
August 25, 2009
Quality of life in patients with metastatic renal cell carcinoma: the importance of patient-reported outcomes
David Cella
Oncology (Williston Park, N.Y.)
|
May 11, 2006
The FDA and the person with cancer: give PROs a chance
David Cella
JAMA Oncology
|
November 26, 2015
Dose Escalation in Stage III Non-Small-Cell Lung Cancer: Patients Agree With the Clinical Results
David Cella
Urology
|
October 11, 2003
Measuring self-reported sexual function in men with prostate cancer
Penny S Brucker, David Cella
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2012
Achieving the best of both worlds
Andrew H Ko, David Cella
Psycho-Oncology
|
March 19, 2019
Bifactor analysis confirmation of the factorial structure of the Functional Assessment of Cancer Therapy-General (FACT-G)
John D Peipert, David Cella
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 28, 2010
Cancer-related fatigue: definitions and clinical subtypes
Barbara F Piper, David Cella
Page
of 102
Search research articles
Search
Showing results (11-20 of 1,016) with videos related to
Sort By:
Page
of 102
Cancer
|
April 3, 2020
In our patient-centered era, it is time we gave patient-reported outcomes their due
David Cella
The Patient
|
July 2, 2022
Concerns about the Responsiveness of Generic Measures and the Search for a "Minimally" Important Change: Today's PRO Red Herrings
David Cella
Seminars in Oncology
|
March 20, 2003
Impact of ZD1839 on non-small cell lung cancer-related symptoms as measured by the functional assessment of cancer therapy-lung scale
David Cella
Cancer Treatment Reviews
|
August 25, 2009
Quality of life in patients with metastatic renal cell carcinoma: the importance of patient-reported outcomes
David Cella
Oncology (Williston Park, N.Y.)
|
May 11, 2006
The FDA and the person with cancer: give PROs a chance
David Cella
JAMA Oncology
|
November 26, 2015
Dose Escalation in Stage III Non-Small-Cell Lung Cancer: Patients Agree With the Clinical Results
David Cella
Urology
|
October 11, 2003
Measuring self-reported sexual function in men with prostate cancer
Penny S Brucker, David Cella
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2012
Achieving the best of both worlds
Andrew H Ko, David Cella
Psycho-Oncology
|
March 19, 2019
Bifactor analysis confirmation of the factorial structure of the Functional Assessment of Cancer Therapy-General (FACT-G)
John D Peipert, David Cella
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 28, 2010
Cancer-related fatigue: definitions and clinical subtypes
Barbara F Piper, David Cella
Page
of 102